Dec 31, 2017

ANI Pharmaceuticals Q4 2017 Earnings Report

Total Revenue
$47.3M
Previous year: $38.2M
+23.8%
EPS
$1.08
Previous year: $0.84
+28.6%
Gross Profit
$26.8M
Previous year: $21.3M
+26.0%
Cash and Equivalents
$31.1M
Previous year: $27.4M
+13.8%
Free Cash Flow
$12.4M
Previous year: $10.7M
+15.6%
Total Assets
$412M
Previous year: $323M
+27.7%

ANI Pharmaceuticals

ANI Pharmaceuticals